Caplin Point Laboratories Ltd.

Financial

	Caplin Point Lab	Gufic Biosciences	Gland Pharma
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	38.0 .	n/a	346.0 .
Number of ANDA's Approved By USFDA	25.0 .	n/a	279.0 .
R&D as a % of Total Sales	4.04 %	1.06 %	4.8 %
Financials
5 yr Average ROE	22.25 %	26.14 %	16.21 %
5yr average Equity Multiplier	1.17	2.82	1.1
5yr Average Asset Turnover Ratio	0.76	1.1	0.54
5yr Avg Net Profit Margin	24.85 %	9.03 %	26.8 %
Price to Book	4.95	8.41	3.43
P/E	23.44	39.03	43.23
5yr Avg Cash Conversion Cycle	64.48 Days	-18.02 Days	141.92 Days
Inventory Days	54.23 Days	77.22 Days	117.9 Days
Days Receivable	88.48 Days	81.36 Days	97.99 Days
Days Payable	76.0 Days	175.58 Days	98.36 Days
5yr Average Interest Coverage Ratio	513.03	10.3	245.99
5yr Avg ROCE	27.4 %	33.27 %	21.37 %
5yr Avg Operating Profit Margin	34.96 %	17.37 %	39.34 %
5 yr average Debt to Equity	0.01	0.73	0.0
5yr CAGR Net Profit	16.34 %	29.43 %	0.21 %
5yr Average Return on Assets	19.05 %	10.17 %	14.66 %
Shareholdings
Promoter Holding	70.62 %	72.51 %	57.86 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.59 %	6.76 %	-0.39 %
Change in Mutual Fund Holding (3 Yrs)	0.61 %	-6.16 %	12.81 %

Business

	Caplin Point Lab	Gufic Biosciences	Gland Pharma
Product Wise Break-Up	Product Wise Break-Up Formulations 75.0 Branded Generics 25.0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0 Injectables 0 Pharmaceuticals 0	Product Wise Break-Up Anti-bacterials 0 CMO 30.0 Cardiovascular 0 Anti-fungals 0 Pharmaceuticals 0 Active Pharmaceutical Ingredient (API) 5.0 Muscle Relaxants 0 Proton pump inhibitors 0 Injectables 0 Domestic Pharmaceuticals 50.0 Branded Generics 0 Formulations 0 International 15.0	Product Wise Break-Up Anti-bacterials 0 CMO 0 Cardiovascular 0 Anti-fungals 0 Pharmaceutical 100.0 API 0 Muscle Relaxants 0 Proton pump inhibitors 0 Injectables 0 Domestic 0 Branded Generics 0 Formulations 0 International 0
Location Wise Break-Up	Location Wise Break-Up Latin America 83.0 USA 14.0 Africa 3.0 India 0 South America 0 Australia 0 North America 0 Europe 0 Asia 0 Rest of the World 0 Canada, Australia & New Zealand 0 Canada 0	Location Wise Break-Up Africa 1.94 Rest of the World 0 Latin America 0 Canada, Australia & New Zealand 0 USA 0 Australia 0.08 India 84.52 Canada 0 South America 0.11 Europe 4.26 North America 1.68 Asia Pacific 7.41	Location Wise Break-Up Africa 0 Rest of the World 0 Latin America 0 Canada, Australia & New Zealand 2.47 USA 53.17 Australia 0 India 4.92 Canada 0 South America 0 Europe 21.04 North America 0 Asia 0 Others 18.4
Distribution Channel	Distribution Channel Distribution 65.0 Pharmacy and Dietary 20.0 Tender Business 15.0 B2C 0 B2B 0	-	Distribution Channel Pharmacy and Dietary 0 Tender Business 0 Distribution 0 B2B 97.51 B2C 2.49
Manufacturing Break-Up	Manufacturing Break-Up India 65.0 China 35.0	-	-

Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd.

SIGN UP FOR FREE